Recent research has centred on the evidence for a decline in intelligence or slowing in the rate of development in early childhood in Down's syndrome and also on the association between Alzheimer-like changes in the brain and possible dementia in later life. At this first meeting of the Forum on Mental Retardation, both psychological and biological aspects of these questions were discussed.
Dr C C Cunningham (Hester Adrian Research Centre, University of Manchester) examined the patterns of development seen in children with Down's syndrome. Psychometric studies generally report on a rapid decline in intelligence quotient (IQ) or developmental quotient (DQ) in the early years, and periods of relatively rapid and slower changes in standard measures of mental and motor development which produce a step-like series of plateaux. Four common explanations (Gibson 1978) are given: (1) that there is a progressive deterioration resulting from secondary neurological, circulatory and/or metabolic anomalies; (2) that behavioural disability does not become manifest until the relevant stages of development are reached and may be related to specific loci of damage; (3) that there are deficits in central and/or receptive systems which impair information-processing and learning and that deterioration may result from a self-perpetuating form of sensory deprivation requiring compensatory teaching approaches; (4) that the pattern of development found may largely be an artefact of the measuring instruments and method of computing the DQ/IQ.
Many studies have averaged scores over large age ranges which obscure the considerable individual variation and staging found. Research at the Hester Adrian Centre on a cohort of 181 infants assessed at six-weekly intervals from birth until 2 years and six-monthly intervals until 5 years found, for example, a range of mental ages from 9 months to 41 months at a chronological age of 36 months (Cunningham et al. 1985) . Confirming the findings of other studies, it was found that parental education, care regimens (e.g. home, institutional or provided with educational opportunities) and additional health difficulties were all correlated with developmental scores. Such factors, as well as the validity of the psychometric measures, are crucial to the deterioration debate.
The most rapid decline in DQ appears in the first year. DQs based on the Bayley Scales of 'Report of the -first meeting of the Forum on Mental Retardation, 9 February 1984. Accepted 5 March 1985 0141 -0768/85/060499-04/$02.00/0 Infant Development (using a sigma score method) report the decline as occurring between 6 and 9 months; but studies using scales which apply the simple ratio method indicate that the decline begins around 10 months of age. Since the simple ratio method assumes a linear relationship between mental age (MA) and chronological age (CA), it is argued that if the MA rises more slowly than CA, the DQ must decline. A comparative study of Down's syndrome infants and normal infants (Dicks-Mireaux 1972) reported a linear curve for the latter but not the former and concluded progressive deterioration imposed on slower growth. Fishler et al. (1964) also found increasing correlations between successive test scores for Down's syndrome children but not for other groups such as cerebral palsy and hypothyroidism and suggested a regression in the early years.
However, if the scales are insensitive to developmental difficulties in the first six months or so, this may exaggerate the decline. The Hester Adrian studies have shown a number of qualitative differences between normal and Down's syndrome infants, suggesting slower information-processing from birth in the latter, and this is confirmed in studies of early social-signalling behaviour, visually directed reaching and auditory preferences (Berger & Cunningham 1981 , Glenn & Cunningham 1983 . Similarly, Cicchetti & Sroufe (1976) found differences in smiling and laughing in Down's syndrome children, suggesting less emotional responsiveness and lower levels of arousal, which correlated with later development. Such measures are not included in standard tests and so a distorted pattern of development may result. These differences may explain slower development without recourse to the concept of physiological deterioration. The longer time needed for information-processing influences the reciprocity of mother-infant interaction, the mothers of Down's syndrome infants tending to have higher levels of maternal activity than those of normal infants, possibly to overcome the lower arousal levels. When this was manipulated by getting mothers to slow down and phase their interactions, significantly higher levels of infant behaviour were seen (Cunningham 1983) .
Variation in the intensity and age of onset of highly intensive early stimulation showed no differences, and when treatment was started at 6 to 10 months the children soon caught up with those where stimulation was started at birth.
It was found that errors in visually directed reaching tended to coincide with the commence-ment of DQ decline (Cunningham 1979) and it seems likely that decline and plateaux in development are related to specific inherent learning difficulties. Thus, the generalized notion of progressive deterioration appears unwarranted and has arisen, at least in part, from simplistic notions of development and artefacts of psychometric testing. Where deterioration does occur it is associated with signs of neurological difficulty, but many children with this condition continue to develop into early adulthood and the effects of early intervention are as yet unclear.
Discussing Dr Cunningham's paper, Dr Janet Carr (St George's Hospital Medical School, London) emphasized that almost all studies, apart from that of Kostrzewski (1974) , have shown a decline in ability levels with age in children with Down's syndrome. This decline is found regardless of which tests are used (Ludlow & Allen 1979 , Morgan 1979 , Ramsay & Piper 1980 and is found on early motor as well as mental scale test scores (Carr 1975) . In one study claiming that decline did not occur, the proportion of children with IQs under 51 almost trebled from before 18 months to 18 months to three years (Berry et al. 1984) . Gibson (1978) suggested that the decline might be due to selective deaths among brighter children although this has not been confirmed in other studies. Carr (1975) found that scores for brighter children, i.e. those in the highest quartile at 11 years old, declined less than those in the lowest quartile at that time, but high scores in infancy (six months) did not predict a slower rate of decline. Early intervention programmes (Ludlow & Allen 1979 , de Coriat et al. 1967 ) did not appear to affect the rate of decline, although scores of the stimulated children were on a higher level than those not receiving specific stimulation.
Whether the decline in IQ is peculiar to those with Down's syndrome is difficult to answer from the available data. Such data as exist (Dubose 1976 , Erickson 1968 , Goodman 1977 suggest that some decline does occur in other mentally handicapped people but, especially in the early years, seems to be rather less common in Down's syndrome. Hence, there may be some common factors (for example, test artefacts) contributing to the decline, while other factors may be unique to people with Down's syndrome.
It will be of crucial importance to see whether intervention programmes can be devised which will alter these well established patterns of development in people with Down's syndrome.
That IQ declines with age in these people should not be taken to mean that their capabilities decrease; on the contrary, they normally continue to learn and acquire new skills as they get older.
Dr R Balazs and Dr B W L Brooksbank (MRC Developmental Neurobiology Unit, London) dis-cussed the biological aspects of ageing in Down's syndrome. They emphasized that Down's syndrome continues to be the major known cause of severe mental retardation, accounting for about 1 per 600 live births, in spite of the fact that about three-quarters of the affected fetuses are spontaneously aborted (Lott 1982) . As this disorder is associated with aneuploidy affecting chromosome 21, the major question in terms of the pathogenesis of Down's syndrome is how the presence of an extra set of normal genes has had an adverse influence on brain development. Currently Down's syndrome is attracting further interest, following observations that besides signs of premature ageing, the prevalence of presenile dementia of the Alzheimer type is very much higher among adult Down's syndrome individuals than in the normal population (Lott 1982) and that the frequency of Down's syndrome in relatives of Alzheimer dementia patients is increased compared with that expected in the general population (Heston 1982) .
In considering the whole Down's syndrome phenotype, the underlying mechanisms are evidently more complex than are accountable to the effects of an extra dose of a single gene. Nevertheless, one of the identified genes on chromosome 21, in particular, may contribute directly to the pathology of Down's syndrome. This gene codes for the cytoplasmic superoxide dismutase (SOD-I), an enzyme catalyzing the formation of H202 from superoxide radicals, and is increased by about 50% in blood cells and cultured fibroblasts in trisomy 21. It has been established that the enzyme activity is also elevated in the brain of Down's syndrome fetuses to a similar degree and is, therefore, consistent with gene dosage effect (Brooksbank & Balazs 1983) .
Unlike in non-neural tissues, no adaptive response of enzyme activities related to the metabolism of oxygen derivatives can be detected in the fetal cerebral cortex in Down's syndrome, suggesting that uncompensated perturbation of the metabolism of oxygen derivatives may render brain cells vulnerable to peroxidative damage.
In addition, in vitro lipoperoxidation is significantly elevated in preparations of Down's syndrome brain, although the level of total combined polyunsaturated fatty acids (PUFA, the major substrates of lipoperoxidation) are apparently normal (Brooksbank & Balazs 1983) . In collaboration with Dr Manuela Martinez (Hospital Infantil, Barcelona) marked differences were, however, observed in the fatty acid composition of certain phospholipids that may account, in part, for the in vitro lipoperoxidation rate. The changes were similar to those occurring during normal cerebral development and accordingly the Down's syndrome brains were apparently 'older' than their chronological age. Thus, the overall potential for lipoperoxidation damage may be increased in the Down's syndrome brain. Such damage which, incidentally, seems to occur during the ageing process (Harrocks et al. 1981) , would result in changes in the fluidity of membranes and in the geometry of surface constituents of cells, modifying functions, such as cell-cell interaction and migration. Furthermore, changes in the integrated functions of cellular membranes, resulting from disturbances in the lipid domains of membrane proteins, may underlie certain of the anomalies of Down's syndrome. This included the increased adrenergic responsiveness of fibroblasts and platelets (Sheppard et al. 1982) as well as the impaired transport of ions and transmitters in platelets (McCoy & Sneddon 1983) and the abnormal electric membrane properties of cultured dorsal root ganglion neurones (Scott et al. 1982) .
Lipoperoxidation may also have direct effects on certain enzymes. In particular, products of PUFA peroxidation are physiological regulators of the soluble guanylate cyclase (Sobolev et al. 1983 ) and such an effect may be involved in the elevation of cyclic guanosine monophosphate (cGMP) levels in Down's syndrome T-lymphocytes (Walford 1982) . As cGMP may serve a second messenger function consequent to the stimulation of certain neurotransmitter receptors, an alteration in the activity of guanylate cyclase may have an important influence on the functioning of transmitter systems in the brain, notably that of acetylcholine. In this respect it may be relevant that as in Alzheimer disease, the central cholinergic system may be affected in Down's syndrome (Yates et al. 1980 ). In addition, a correlation has been found between the activity of choline acetyltransferase pyruvate dehydrogenase both under normal conditions and in diseases affecting the cholinergic system (as in Alzheimer) and it has been observed that the proportion of pyruvate dehydrogenase in the active forms is reduced in Down's syndrome fibroblasts (Sorbi et al. 1982) .
It should be remembered that the complex Down's syndrome phenotype is most likely the result of a cumulative effect of the increased concentration of a large number of gene products, compounded by secondary reactions triggered by the imbalance of the genome (Epstein et al. 1982) . The elucidation of the mechanisms involved will be facilitated by the discovery that some of the genes (including SOD-I) coded in man on chromosome 21 are located in the mouse on chromosome 16 and that it is possible to produce experimentally mouse embryos with trisomy 16 (Gropp 1982) .
Professor John Dickerson (University of Surrey, Guildford) concluded that reports of Alzheimertype presenile dementia occurring at earlier ages and more frequently in people with Down's syndrome suggest that studies of the brain in this condition may give important clues about the causes of dementia. Studies have shown that Down's syndrome can be recognized in the fetus (Brooksbank & Balazs 1983 , P E Sylvester 1984 , and it would be interesting to know how early the structural changes similar to those occurring in Alzheimer disease are seen.
The enzyme SOD, found to be raised in the brain in Down's syndrome fetuses, catalyzes the production of hydrogen peroxide (H202) from superoxide (20i + 2H +-H202 +02) SOD is a copper-zinc metalloprotein. The hydrogen peroxide produced by this reaction is destroyed by another enzyme, glutathione reductase, which catalyzes the reaction of reduced glutathione with hydrogen peroxide. The results of Balasz and Brooksbank raise a number of questions. First, it would be of interest to know if the raised levels of SOD in the brains of Down's syndrome fetuses result in higher levels of H202 or simply in a greater activity of the sequence Oa--H202-*H20 and whether there is in Down's syndrome brains an imbalance between SOD and glutathione reductase? Also, is there a greater requirement for reduced glutathione in the brains of Down's syndrome subjects, and is the raised SOD activity in Down's syndrome fetuses reflected by an increase in the brains of Down's syndrome adults?
Lipid peroxidation results in deterioration of tissues by virtue of changes in cell membranes. Peroxide formation results in the production of free radicals (ROO', RO'+OH'). These resite at random to damage enzymes, proteins and other lipids and vitamins and such reactions are inhibited by radical trapping agents such as the tocopherolsvitamin E. It would be of interest to see whether supplements of vitamin E would be beneficial in Down's syndrome by virtue of their effect on peroxidation and 'mopping up' free radicals.
The changes in fatty acid composition described by Balazs and Brooksbank indicated that Down's syndrome brains were physiologically or biochemically older than their chronological age. The associated changes in membrane structure might well affect the activities of membrane-bound enzymes and the transport of materials across the membranes. A further question is whether there is a similarity between the changes described in Down's syndrome brains and those reported in red cell membranes of patients with endogenous depression (Fehily et al. 1981) . These workers suggested that, in depressives, changes in the fatty acids of membrane lipids could alter the activity of the membrane-bound Na + K + ATPase (Hesketh etal. 1977) . A further question is whether changes in membrane structure affect organs other than the brain. The membrane of the intestinal mucosal cells plays an important role in the absorption of nutrients from the gut. Xylose absorption is abnormally low in children (Chapman et al. 1966) and adults with Down's syndrome (C A Williams et al., in preparation) and it has been suggested that vitamin deficiencies found in Down's syndrome could be due to malabsorption (Matin et al. i981 ).
Low levels of certain other minerals have been reported in the hair of Down's syndrome subjects (Barlow et al. 1981) . It is always tempting, when low levels of nutrients are found, to think of supplementation. However, the enzyme, which is elevated in the brains of Down's syndrome fetuses contains copper and it might be that copper supplement would further exacerbate the condition.
Thus, the observations of Balazs and Brooksbank could have far-reaching significance, particularly if it could be shown that similar changes in lipid composition are present in membranes other than those in the brain.
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